Skip to main content

Advertisement

Log in

Ommaya reservoir in the treatment of cryptococcal meningitis

  • Original Article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

The objective is to study the role of Ommaya reservoir in the treatment of cryptococcal meningitis. The clinical data of 42 patients with cryptococcal meningitis were retrospectively studied. The Ommaya group included 20 patients, who were treated with Amphotericin B (Am B) and Ommaya reservoir implantation. The non-Ommaya group contained 22 patients, who were just treated with Amphotericin B (Am B). In the Ommaya group (surgical group), all 20 patients with Ommaya reservoir were fully recovered, and their average hospital stay period and average treatment period with Amphotericin B were 105.3 ± 18.3 and 75.0 ± 18.1 days, respectively. In the non-Ommaya group (control group), 16 patients were fully recovered and the average hospital stay period and average treatment period with Amphotericin B of these 22 patients were 139.6 ± 29.5 and 150.0 ± 32.2 days, respectively. In the surgical group, average period of cryptococcus disappearance was 20 ± 8 days, while in the control group, that was 35 ± 10 days. The clinical efficacy was better in surgical group than control group (P < 0.05). Ommaya reservoir implantation is a valuable approach in the treatment of cryptococcal meningitis and can improve the cure rate, decrease mortality, and shorten the period of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Corbett EL, Churchyard GJ, Charalambos S, Samb B, Moloi V, Clayton TC (2002) Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis 34:1251–1258

    Article  PubMed  Google Scholar 

  2. Jenney A, Pandithage K, Fisher DA, Currie BJ (2004) Cryptococcus infection in tropical Australia. J Clin Microbiol 42:3865–3868

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME (2003) The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992–2000. Clin Infect Dis 36:789–794

    Article  PubMed  Google Scholar 

  4. Coenjaerts FE, van der Flier M, Mwinzi PN, Brouwer AE, Scharringa J, Chaka WS (2004) Intrathecal production and secretion of vascular endothelial growth factor during Cryptococcal Meningitis. J Infect Dis 190:1310–1317

    Article  CAS  PubMed  Google Scholar 

  5. Sheldon P, Ommaya AK (1963) Ventricular dilatation masking the presence of cerebral tumours. Acta Radiol Diagn (Stockh) 1:628–637

    CAS  Google Scholar 

  6. Mechleb B, Khater F, Eid A, David G, Moorman JP (2003) Late onset Ommaya reservoir infection due to Staphylococcus aureus: case report and review of Ommaya Infections. J Infect 46:196–198

    Article  CAS  PubMed  Google Scholar 

  7. Obbens EA, Leavens ME, Beal JW, Lee YY (1985) Ommaya reservoirs in 387 cancer patients: a 15-year experience. Neurology 35:1274–1278

    Article  CAS  PubMed  Google Scholar 

  8. Polsky B, Depman MR, Gold JW, Galicich JH, Armstrong D (1986) Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. Am J Med 81:24–28

    Article  CAS  PubMed  Google Scholar 

  9. Dickerman RD, Eisenberg MB (2005) Preassembled method for insertion of Ommaya reservoir. J Surg Oncol 89:36–38

    Article  PubMed  Google Scholar 

  10. Jiang PF, Zhu T (2005) A case of cryptococcal meningitis successfully treated with placing Ommaya reservoir into ventricle. Zhonghua Er Ke Za Zhi 43:470–471

    PubMed  Google Scholar 

  11. Nakama T, Yamashita S, Hirahara T, Okamoto S, Honda S, Watanabe M, Kimura E, Uchino M, Yano S, Kuratsu J, Ando Y (2015) Usefulness of intraventricular infusion of antifungal drugs through Ommaya reservoirs for cryptococcal meningitis treatment. J Neurol Sci 358:259–262

    Article  CAS  PubMed  Google Scholar 

  12. Jiang PF, Yu HM, Zhou BL, Gao F, Shen SX, Xia ZZ, Shui QX (2010) The role of an Ommaya reservoir in the management of children with cryptococcal meningitis. Clin Neurol Neurosurg 112:157–159

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jing Wan or Yanggan Wang.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

The study protocol was approved by Zhongnan Hospital Bioethics Committee of Wuhan University.

Informed consent

Written informed consent was obtained from the patient.

Additional information

Baozhu Wei and Cheng Qian are contributed equally and should be treated as co-first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wei, B., Qian, C., Liu, Y. et al. Ommaya reservoir in the treatment of cryptococcal meningitis. Acta Neurol Belg 117, 283–287 (2017). https://doi.org/10.1007/s13760-016-0682-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-016-0682-6

Keywords

Navigation